Thyroid and reproductive hormones disruption as well as kallikrein-3 level in dimethyl nitrosamine-induced toxicity: Effects of ascorbate treatment in male wistar rats  by Somade, Oluwatobi T. et al.
Available online at www.sciencedirect.comScienceDirect
Biochimie Open 3 (2016) 40e46
http://www.journals.elsevier.com/biochimie-openResearch paper
Thyroid and reproductive hormones disruption as well as kallikrein-3 level
in dimethyl nitrosamine-induced toxicity: Effects of ascorbate treatment in
male wistar rats
Oluwatobi T. Somade*, Regina N. Ugbaja, Olubisi E. Adeyi, Damilola M. Ogunberu
Department of Biochemistry, College of Biosciences, Federal University of Agriculture Abeokuta, Abeokuta, Nigeria
Received 17 August 2016; accepted 20 September 2016
Available online 28 September 2016AbstractInformation on dimethyl nitrosamine (DMN)-induced toxicity on endocrine functions is still scanty. This study therefore investigated the
outcomes of DMN-induced toxicity on endocrine (thyroid and reproductive) functions, as well as kallikrein-3 level, and effects of ascorbate
treatments in male wistar rats. Thirty animals divided into six groups of five rats each were used. Group I animals were the normal control, group
II animals served as vehicle control and were administered a single intraperitoneal dose of normal saline, groups III and IV were intraperi-
toneally injected with a single dose of 30 mg/kg DMN for 48 h, but group IV animals were post-treated orally with 5.71 mg/kg body weight
(400 mg/70 kg) ascorbate for seven days, group V animals were pre-treated with same dose of ascorbate orally for seven days before intra-
peritoneal injection of DMN, while group VI animals were orally administered ascorbate only for seven days. Compared with control, DMN
administration resulted in significant decrease (p < 0.05) in serum total cholesterol, testosterone (TST), luteinizing hormone (LH), free triio-
dothyronine (fT3), and kallikrein III (KLK-3) levels, as well as non-significant increase in serum thyroid stimulating hormone (TSH) level. Pre-
treatment with ascorbate significantly increase LH and KLK-3 levels, while post-treatment significantly increase fT3 level. Also, pre-treatment
with ascorbate significantly reduced TSH level, while there was no significant difference in TST level following ascorbate treatments. From our
findings and to some extent, ascorbate demonstrates ameliorative effects against DMN-induced hormonal disruption in male wistar rats, and this
may be attributed to its antioxidant property.
© 2016 The Authors. Published by Elsevier B.V. on behalf of Socie´te´ Franc¸aise de Biochimie et Biologie Mole´culaire (SFBBM). This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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N-nitroso compounds (NOCs) are well established carcin-
ogens present in a vast variety of food stuffs such as smoked
fish, dried malt, beer, milk products, meat products, and pre-
served fruit juices [1e3]. Among various NOCs, dimethyl
nitrosamine (DMN) is a well-known carcinogen, mutagen, and
hepatotoxin [4,5], present in tobacco smoke, high nitrates* Corresponding author.
E-mail addresses: toblerum@yahoo.co.uk, somadeot@funaab.edu.ng (O.T.
Somade).
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2214-0085/© 2016 The Authors. Published by Elsevier B.V. on behalf of Socie´te´ Fra
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-ncontaining water, fried meals, cosmetics, pharmaceutical
agents, and agricultural chemicals [6].
DMN targets primarily the liver, which contains the
necessary enzymes for its metabolic activation. Metabolism in
the liver is by a microsomal membrane-bound enzyme, cyto-
chrome P-450 2E1 [7e9]. DMN exerts carcinogenic effects
and induces hepatic necrosis through metabolic activation by
cytochrome P450 2E1 [10] in experimental animals. The for-
mation of reactive oxygen species (ROS) like H2O2, super-
oxide anion ðO2Þ and hydroxyl radicals (OH$) has been
demonstrated during the metabolism of nitrosamines resulting
in oxidative stress, which may be one of the key factors in the
induction of pathological conditions such as hepatocellularnc¸aise de Biochimie et Biologie Mole´culaire (SFBBM). This is an open access
c-nd/4.0/).
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mation [11e13].
The most abundant and effective antioxidant in the human
body is ascorbic acid [14]. Due to these, the present study
checked the effects of treatments with ascorbate on thyroid
and reproductive hormones disruption as well as kallikrein-3
level in DMN-induced toxicity in male wistar rats.
2. Materials and methods2.1. Test substance and kitsDMN (purity  98%) used in this study were of analytical
grade, product of Sigma Chemical Co., Saint Louis, MO,
USA. Ascorbate (vitamin C) was purchased from Kunimed
Pharmachem Limited, Lagos, Nigeria. Total cholesterol
(TCHOL) kit used, is a product of Cypress Diagnostics,
Langdorp, Belgium, while TST, LH, fT3, TSH, and KLK III
enzyme immunoassay (EIA) test kits were products of Bio-
Inteco Diagnostic Limited, Beechwood Road, England.2.2. Experimental animals and study designThirty (30) male wistar albino rats of an average weight of
250 g used for this study were obtained from the animal house
of the College of Veterinary Medicine, Federal University of
Agriculture, Abeokuta, Nigeria. They were housed in steel
metal cages in the animal house of our department and were
served food and water ad libitum. Permission to use the ani-
mals was approved by the Institution's Animal Ethical Com-
mittee. After a long period of acclimatization, the rats were
divided randomly into six groups (IeVI) of five animals each,
and were administered as presented below:
Group I: animals served as normal control and were served
food and water throughout the study.
Group II: animals served as vehicle control and were
administered a single intraperitoneal dose of 6 mL/kg normal
saline.
Groups III: animals were administered 30 mg/kg single
intraperitoneal dose of DMN [15] for forty eight (48) hours
only.
Group IV: animals were administered 30 mg/kg single
intraperitoneal dose of DMN, followed by oral post-treatment
with 5.71 mg/kg (400 mg/70 kg) ascorbate for seven (7) days.
Group V: animals were orally pre-treated with 5.71 mg/kg
ascorbate for 7 days, followed by a single intraperitoneal dose
of 30 mg/kg DMN for 48 h.
Group VI: animals were orally administered ascorbate for 7
days.2.3. Sample collections and preparationsAt the end of the experimental period, the animals were
sacrificed by cervical dislocation. They were handled and used
in accordance with the international guide for the care and use
of laboratory animals [16]. Blood samples were collected from
the abdominal artery into clean plain tubes, and were allowedto stand for 20e30 min; followed by centrifugation at
3000 rpm for 10 min. Serum was separated and aliquoted into
clean 1 ml Eppendorf tubes, and stored at 18 C until when
used.2.4. Determination of total cholesterol concentrationSerum TCHOL was determined according to the methods
described in Cypress Diagnostics Kits, Langdorp, Belgium.
Briefly, cholesterol esterase hydrolyzed cholesterol esters to
release free cholesterol which was oxidized by cholesterol
oxidase, and the resulting hydrogen peroxide (H2O2) reacted
with 4-aminophenazone and phenol to form a red quinonimine
dye, whose color intensity is proportional to the cholesterol
concentration.2.5. Estimations of serum levels of TST, LH, fT3, TSH,
and kallikrein-3These were done as described in Bio-Inteco Diagnostic EIA
test kits, based on antibody-antigen reactions. As a result, the
developed color intensities which are directly proportional to
the concentrations in the test samples were measured
spectrophotometrically at 450 nm using BioTek ELx800
Microplate reader (Northstar Scientific Limited).2.6. Statistical analysisData were analyzed by one-way analysis of variance
(ANOVA), followed by least significant difference (LSD) to
test for significant differences among the groups of rats
using Statistical Package for Social Sciences program
version 17.0. Data were expressed as mean ± standard error
of mean. p values less than 0.05 were considered statisti-
cally significant.
3. Results3.1. Effects of ascorbate treatments on serum
TCHOL concentrationDMN administration significantly (p < 0.05) reduced the
concentration of serum TCHOL concentration when compared
with control (Fig. 1), while pre- and post-treatment with
ascorbate did not have any significant effect (p > 0.05) on its
levels (Fig. 1).3.2. Effects of ascorbate treatments on serum LH and
TST levelsCompared with control, DMN administration resulted in
significant decrease (p < 0.05) in LH (Fig. 2) and TST (Fig. 3)
levels. Ascorbate pre- and post-treatments resulted into sig-
nificant (p < 0.05) and non-significant increase (p > 0.05) in
LH levels respectively (Fig. 2), while both forms of treatments
did not have any significant (p > 0.05) effects on the TST
levels (Fig. 3).
Fig. 1. Effects of pre- and post-ascorbate treatments on total cholesterol levels in DMN- induced toxicity. Values are expressed as mean ± SEM (n ¼ 5). Bars with
different letters are significantly different (p < 0.05), while bars with similar letters are not significant (p > 0.05). DMN ¼ dimethyl nitrosamine;
ASCB ¼ ascorbate.
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fT3 levelsThere was a non-significant increase (p > 0.05) in TSH
level (Fig. 4), and a significant (p < 0.05) decrease in fT3 level
(Fig. 5), accompanying DMN administration compared with
control. Pre-treatment only with ascorbate significantly
(p < 0.05) decrease TSH level (Fig. 4), while fT3 level was
significantly (p < 0.05) increased by post-treatment with
ascorbate (Fig. 5).3.4. Effects of ascorbate treatments on serum
KLK-3 levelsDMN administration significantly (p < 0.05) decreased in
KLK-3 level when compared with control (Fig. 6), but only
pre-treatment with ascorbate that was able to significantly
(p < 0.05) increase the levels back to level comparable with
control.Fig. 2. Effects of pre- and post-ascorbate treatments on LH levels in DMN- induce
letters are significantly different (p < 0.05), while bars with similar letters are not4. Discussion
The present study was carried out to investigate the effects
of DMN-induced toxicity on some reproductive, thyroid hor-
mones as well as KLK-3 levels, and the role of pre- and post-
ascorbate treatments in rats. One of the key functions of
cholesterol in animals is to serve as a pre-cursor to the
biosynthesis of steroid hormones [17]. The significant
decrease in TCHOL concentrations (Fig. 1) following DMN
administration may be due to alteration in the hepatic syn-
thesis of this lipid. DMN-induced toxicity could also have
altered other biological molecules that require cholesterol as
precursor (e.g. bile acid), and consequently, the availability of
the lipid may have been channeled to their synthesis. Some of
the compounds that have also been reported to decrease serum
or plasma TCHOL are sodium azide [18], and carbon tetra-
chloride [19].
LH is also referred to as lutrophin [20], and is produced by
gonadotropic cells in the anterior pituitary gland. In females, itd toxicity. Values are expressed as mean ± SEM (n ¼ 5). Bars with different
significant (p > 0.05). DMN ¼ dimethyl nitrosamine; ASCB ¼ ascorbate.
Fig. 3. Effects of pre- and post-ascorbate treatments on TST levels in DMN- induced toxicity. Values are expressed as mean ± SEM (n ¼ 5). Bars with different
letters are significantly different (p < 0.05), while bars with similar letters are not significant (p > 0.05). DMN ¼ dimethyl nitrosamine; ASCB ¼ ascorbate.
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produce TST [21]. Pituitary gland releases LH, and is
controlled by actions of gonadotropin releasing hormone
(GnRH). Following low levels of TST, hypothalamus releases
GnRH, stimulating the pituitary gland to produce LH [22]. In
this present study, DMN-induced toxicity significantly
decreased serum LH level (Fig. 2), suggesting an interference
of DMN with anterior pituitary, leading to lack of LH secre-
tion. Also, it may be due to decreased secretion of GnRH by
the hypothalamus, or failure of the anterior pituitary to
respond to GnRH stimulation. Similar findings have been re-
ported in rats following morphine [23e26], and alcohol ex-
posures [27,28]. Streptozotocin-induced diabetic rats have also
been reported to have low levels of LH [29]. Amelioration by
ascorbate pre-treatment may be attributed to its antioxidant
and cyto-protective properties against free radical damage
[30,31] that may have protected the hypothalamicepituitary
axis against free radical attack.Fig. 4. Effects of pre- and post-ascorbate treatments on TSH levels in DMN- induc
letters are significantly different (p < 0.05), while bars with similar letters are notTST, a steroid hormone belonging to the androgen class, is
found in humans and other vertebrates. 11-ketotestosterone
[32] and ecdysone [33] are slightly different forms of TST
found in fish and insects respectively. TST plays a major role
in the development of male reproductive tissues such as testis
and prostate in men. It also promotes secondary sexual char-
acteristics including increased bone and muscle mass, and
growth of body hair [34]. Also, TST is important for the
prevention of osteoporosis [35], and for health and well-being
[36]. Levels of TST are greater in adult male than female
adults [37]. The significant decrease in serum TST (Fig. 3)
obtained in this study can be attributed to the significant
decrease in serum TCHOL recorded, being a precursor to
steroid hormone synthesis [38]. LH stimulates leydig cells of
the testes to produce TST [21,22]. Therefore, the decreased
level of serum TST recorded can be attributed to the low LH
levels. Our findings are corroborated by the studies of Bazzano
et al. [39] and Ochiogu et al. [40], who reported low serumed toxicity. Values are expressed as mean ± SEM (n ¼ 5). Bars with different
significant (p > 0.05). DMN ¼ dimethyl nitrosamine; ASCB ¼ ascorbate.
Fig. 5. Effects of pre- and post-ascorbate treatments on fT3 levels in DMN- induced toxicity. Values are expressed as mean ± SEM (n ¼ 5). Bars with different
letters are significantly different (p < 0.05), while bars with similar letters are not significant (p > 0.05). DMN ¼ dimethyl nitrosamine; ASCB ¼ ascorbate.
Fig. 6. Effects of pre- and post-ascorbate treatments on KLK-3 levels in DMN- induced toxicity. Values are expressed as mean ± SEM (n ¼ 5). Bars with different
letters are significantly different (p < 0.05), while bars with similar letters are not significant (p > 0.05). DMN ¼ dimethyl nitrosamine; ASCB ¼ ascorbate.
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administration in humans and West African Dwarf goats
respectively. Also, Manjunath et al. [29] reported low TST and
LH levels in streptozotocin-induced diabetic rats. Free
radicals-induced tissue damage has been reported as a mech-
anism of action of DMN [12,13]. Therefore, ineffectiveness of
ascorbate treatment on serum TST levels is suggested to be
due to free radical damage on testicular leydig cells [41],
rendering them unresponsive to LH stimulation to produce
TST.
TSH or thyrotropic hormone is a pituitary and glycoprotein
hormone synthesized and secreted by thyrotrope cells in the
anterior pituitary gland, regulating the endocrine function of
the thyroid [42]. TSH stimulates thyroid gland to produce
thyroxine (T4), and triiodothyronine (T3) which is responsible
for the metabolism of virtually all tissues in the body [43].When there is low level of thyroid hormone in the blood, high
thyroid-releasing hormone (TRH) is released by the hypo-
thalamus, so high TSH is secreted by the pituitary [44] to
produce thyroid hormones [43]. Therefore, from this study, the
increase in TSH level (Fig. 4), although not significant
following DMN administration may be due to the low level of
fT3 (Fig. 5).
T3 is a thyroid hormone that affects almost every physio-
logical process in the body. It is circulated in blood almost
completely bound to carrier proteins [45], known as thyroxine
binding globulin (TBG) [45]. However, only the unbound
portion of T3 (fT3) is known to be the true hormone respon-
sible for biological actions [43]. Only 20% of thyroid hormone
produced is T3, appreciable amount (85%) of the circulating
T3 is therefore formed from T4 in the liver and pituitary [43].
Also, the significant decrease in fT3 level (Fig. 5) as a result
45O.T. Somade et al. / Biochimie Open 3 (2016) 40e46DMN administration may be attributed to inability of the liver
to activate T4 to T3, due to hepatic damage. DMN has been
reported to have carcinogenic effects and induces hepatic ne-
crosis in experimental animals [10]. As a component of to-
bacco smoke condensate and certain alcoholic beverages,
DMN can induce lung, liver or renal cancers [46,47].
PSA, also known as KLK-3 is a glycoprotein enzyme,
secreted by the epithelial cells of the prostate gland. KLK-3 is
needed for the ejaculate, where it liquefies semen in the
seminal coagulum, enabling sperm to swim freely [48]. KLK-
3 is available in serum of men with healthy prostates in small
quantities, but is usually elevated in the presence of prostate
cancer or other prostate disorders [49]. From this present
study, there was a significant reduction in KLK-3 level
(Fig. 6). Though DMN is known to be a potent hepatotoxin,
mutagen and carcinogen as already reiterated, administration
of DMN may not play a role in the etiology of prostate cancer.
5. Conclusion
From our findings, DMN administration led to hormonal
disruption and ascorbate treatments demonstrate to some
extent, degree of amelioration which may be attributed to its
antioxidant [50e52] and cyto-protective properties.
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